Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : CELSION CORP. (CLN was CELN) UP $.33 TO $.59 ON HUGE NEWS -- Ignore unavailable to you. Want to Upgrade?

To: sun who wrote (216)	1/31/1999 12:53:00 AM
From: Dave Gore	Read Replies (3) \| Respond to of 518

**** So 22 mil shares in the float and at least 2-3 years before approval Folks be careful.... this has very wonderful potential and is a very emotional topic, but you all understand that the news only gave them approval to begin Phase 1 testing. Phase 2 is at least 6 -9 months off and Phase 3 is several more months or years off. Then final approval by the FDA is years down the road, if it comes at all. I am very familiar with biotech stocks and they take incredible patience and usually require a major funding partner at some point. It took investor's in Immunex several years before approval of Embrol and the subsequent stock run up. This will probably go up anyway....but just be smart.... these MM's are VERY VERY tricky on this stock. I watched it all Friday. If you get in, get in quick and out quick...don't chase this and don;t get greedy. Watch those Market orders...the MM's will screw you big.